Ohki Health Care Holdings, Inc. (JP:3417)
:3417
Want to see JP:3417 full AI Analyst Report?
Top Page
Ohki Health Care Holdings, Inc.
(3417)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥1,409.00
▼(-0.91% Downside)
Action:Reiterated
Date:05/17/26
The score is held back mainly by weak recent cash flow (negative operating and free cash flow for two years) and softer profitability, despite steady revenue growth. Technicals are neutral with modestly positive momentum, and valuation appears reasonable with a mid P/E and moderate dividend yield.
Positive Factors
Steady revenue growth
Consistent top-line growth across multiple years indicates resilient demand for pharmaceutical distribution services and strengthens the company's ability to maintain scale in purchasing and logistics. Durable revenue expansion supports long-term contract leverage, supplier relationships, and incremental margin opportunities even if margins remain thin.
Negative Factors
Weak cash generation
Consecutive years of negative operating and free cash flow signal persistent working-capital or conversion issues. That reduces financial flexibility, limits organic reinvestment, and forces greater reliance on external financing or debt, increasing vulnerability to interest cost moves and constraining strategic initiatives over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
Consistent top-line growth across multiple years indicates resilient demand for pharmaceutical distribution services and strengthens the company's ability to maintain scale in purchasing and logistics. Durable revenue expansion supports long-term contract leverage, supplier relationships, and incremental margin opportunities even if margins remain thin.
Read all positive factors
Ohki Health Care Holdings, Inc. (3417) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥18.69B
Dividend Yield1.83%
Average Volume (3M)8.64K
Price to Earnings (P/E)14.6
Beta (1Y)0.49
Revenue Growth3.12%
EPS Growth-49.26%
CountryJP
Employees632
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)207.61
Shares Outstanding14,072,100
10 Day Avg. Volume11,730
30 Day Avg. Volume8,636
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.53
Price to Sales (P/S)0.05
P/FCF Ratio-6.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ohki Health Care Holdings, Inc. Business Overview & Revenue Model
Company Description
Ohki Healthcare Holdings Co.,Ltd. distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities. The company imports, exports, and sells pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and ...
How the Company Makes Money
Ohki Health Care Holdings, Inc. primarily makes money by wholesaling and distributing healthcare products—earning revenue from the sale of pharmaceuticals and other health-related goods procured from manufacturers and sold onward to customers such...
Ohki Health Care Holdings, Inc. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 352.90B | 360.36B | 349.45B | 334.66B | 304.44B | 278.16B |
| Gross Profit | 19.01B | 17.24B | 18.19B | 16.89B | 15.58B | 13.42B |
| EBITDA | 3.45B | 1.17B | 3.16B | 2.42B | 2.44B | 981.00M |
| Net Income | 2.83B | 1.34B | 2.64B | 2.21B | 2.18B | 971.00M |
Balance Sheet | ||||||
| Total Assets | 141.50B | 148.39B | 140.96B | 140.08B | 123.96B | 115.39B |
| Cash, Cash Equivalents and Short-Term Investments | 3.49B | 2.21B | 2.88B | 8.31B | 3.24B | 2.77B |
| Total Debt | 13.41B | 15.62B | 14.21B | 6.95B | 8.48B | 7.50B |
| Total Liabilities | 110.48B | 114.22B | 109.90B | 112.18B | 99.68B | 93.29B |
| Stockholders Equity | 30.96B | 34.16B | 30.99B | 27.84B | 24.13B | 21.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.74B | -12.03B | 7.27B | -138.00M | 1.22B |
| Operating Cash Flow | 0.00 | -1.42B | -9.18B | 7.55B | 96.00M | 1.31B |
| Investing Cash Flow | 0.00 | -671.00M | -3.13B | -496.00M | -291.00M | 68.00M |
| Financing Cash Flow | 0.00 | 1.42B | 6.89B | -2.00B | 681.00M | -1.40B |
Ohki Health Care Holdings, Inc. Technical Analysis
Positive
1422.00
Price Trends
1334.74
Positive
1365.37
Negative
1314.41
Positive
Market Momentum
7.11
Negative
51.53
Neutral
44.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Positive. The current price of 1422 is above the 20-day moving average (MA) of 1348.72, above the 50-day MA of 1334.74, and above the 200-day MA of 1314.41, indicating a bullish trend. The MACD of 7.11 indicates Negative momentum. The RSI at 51.53 is Neutral, neither overbought nor oversold. The STOCH value of 44.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3417.
Ohki Health Care Holdings, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥204.83B | 12.71 | ― | 2.35% | 7.84% | 17.59% | |
67 Neutral | ¥368.12B | 16.82 | ― | 0.41% | 14.59% | 7.84% | |
66 Neutral | ¥580.69B | 17.44 | 15.71% | 0.96% | 15.07% | 72.98% | |
62 Neutral | ¥947.68B | 19.41 | ― | 1.72% | ― | ― | |
60 Neutral | ¥499.01B | 16.97 | ― | 0.93% | 6.74% | 6.60% | |
58 Neutral | ¥18.69B | 14.56 | ― | 1.83% | 3.12% | -49.26% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3417
Ohki Health Care Holdings, Inc.
1,355.00
311.19
29.81%
JP:7649
Sugi Holdings Co
3,081.00
-12.40
-0.40%
JP:3391
TSURUHA Holdings
2,106.50
-90.57
-4.12%
JP:3148
Create SD Holdings Co., Ltd.
3,240.00
194.97
6.40%
JP:3349
COSMOS Pharmaceutical Corporation
6,269.00
-2,744.15
-30.45%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,850.00
322.32
9.14%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.